Is Your Drugstore Selling Your Private Information to Big Pharma?

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.


For years, the big drugstore chains have stoutly denied selling prescription information—patient names, contact information, doctors’ names, and prescription details—to pharmaceutical companies for marketing use. Now, that charade has come to an end with two class action  suits, accusing CVS and Walgreen of doing just that.

In a civil suit in Philadelphia County Court, as Courthouse News reports, the city’s teachers union charged that consumers got unsolicited sales pitches after CVS allegedly sold customers’ private information to Eli Lilly and Co., Merck, AstraZeneca, Bayer, and other drug manufacturers. The union’s claim states:

 “Specifically, in exchange for the receipt of funds, direct promotional letters were sent to physicians of consumers by  defendant CVS Caremark in order to promote and tout specific prescription drugs of pharmaceutical manufacturers who contracted   with defendant CVS Caremark” for use of prescription information, according to the complaint.      

“While touted as an ‘RXReview Program’ by defendant CVS   Caremark, in reality, the physician communications were nothing more than a profit-making opportunity,” the class claims.

CVS’s scheme contradicts its “public pronouncements as to the sanctity of both consumers’ privacy and the physician-patient relationship,” according to the complaint.

Courthouse News goes on to report: “In 2009, CVS settled related claims from the Department of  Health and Human Services and Federal Trade Commission. Under the agreement with the health department, CVS paid $2.25 million to   settle claims related to  media reports that its pharmacies were throwing pill bottles with customers’ personal information into open dumpsters.”

A second law suit, in California, alleges that Walgreen unlawfully sold medical information gleaned from patient prescriptions, according to a Reuters report. In this case the plaintiffs accuse “Walgreen of depriving them of the commercial value of their own prescription information.’’

According to the suit, brought by Todd Murphy on behalf of his two daughters and the rest of the class of consumers, Walgreen sells the prescription information to data mining companies who resell it to pharmaceutical companies for marketing purposes. The practice allows drugmakers to target physicians considered high-volume prescribers and those most willing to prescribe new medications, it said.

So what’s the point of all this? If the facts in these suits prove to be correct, then when you take a prescription down to CVS or Walgreen, you are effectively releasing the information to just about everybody in the drug and related industries. It most certainly opens you to the possibility of a blizzard of pitches. And it opens the door for pitches to doctors to prescribe the same or possibly different new drugs. In addition, there’s no guarantee that this information won’t follow you around when you go to get a health insurance or life insurance policy. In short, your most personal health information–what medications you take, and for what conditions–is available to anyone who has the price of admission.

We've never been very good at being conservative.

And usually, that serves us well in doing the ambitious, hard-hitting journalism that you turn to Mother Jones for. But it also means we can't afford to come up short when it comes to scratching together the funds it takes to keep our team firing on all cylinders, and the truth is, we finished our budgeting cycle on June 30 about $100,000 short of our online goal.

This is no time to come up short. It's time to fight like hell, as our namesake would tell us to do, for a democracy where minority rule cannot impose an extreme agenda, where facts matter, and where accountability has a chance at the polls and in the press. If you value our reporting and you can right now, please help us dig out of the $100,000 hole we're starting our new budgeting cycle in with an always-needed and always-appreciated donation today.

payment methods

We've never been very good at being conservative.

And usually, that serves us well in doing the ambitious, hard-hitting journalism that you turn to Mother Jones for. But it also means we can't afford to come up short when it comes to scratching together the funds it takes to keep our team firing on all cylinders, and the truth is, we finished our budgeting cycle on June 30 about $100,000 short of our online goal.

This is no time to come up short. It's time to fight like hell, as our namesake would tell us to do, for a democracy where minority rule cannot impose an extreme agenda, where facts matter, and where accountability has a chance at the polls and in the press. If you value our reporting and you can right now, please help us dig out of the $100,000 hole we're starting our new budgeting cycle in with an always-needed and always-appreciated donation today.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate